Equity Analysis /
United States of America

US : Global Blood Therapeutics, Inc. - GBT | In-Line 3Q for Oxbryta but Outlook Signaling a Plateau; Expectations for '061 ASH Data Reset

    Danielle Brill
    CGS-CIMB
    5 November 2021
    Published by